Magnesium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulfate ## Overview Magnesium sulfate is an essential mineral that plays a vital role in numerous physiological processes, including muscle and nerve function, blood glucose control, and blood pressure regulation. It is available for intravenous (IV) and intramuscular (IM) administration. ## Primary Indications * Hypomagnesemia * Eclampsia and severe preeclampsia * Torsades de Pointes * Bronchospasm (adjunctive therapy) * Severe asthma exacerbation (adjunctive therapy) ## Adult Dosing * **Hypomagnesemia:** * Severe deficiency: 4-6 grams IV initially, followed by 2-4 grams every 4-6 hours for 24-48 hours, or as a continuous infusion of 1-2 grams/hour. * Less severe deficiency: 1-2 grams IV or IM every 6 hours for 3-4 doses. * **Eclampsia/Preeclampsia:** * Loading dose: 4-6 grams IV infused over 5-10 minutes. * Maintenance dose: 1-2 grams/hour IV infusion. Alternatively, 5 grams IM into each buttock every 4 hours. Dosing may vary based on local protocols and patient response. * **Torsades de Pointes:** 1-2 grams IV, often as a rapid infusion (e.g., over 5-10 minutes), followed by a continuous infusion of 0.5-1 gram/hour. * **Bronchospasm/Asthma:** 1-2 grams IV infused over 15-20 minutes. ## Pediatric Dosing * **Hypomagnesemia:** Dosing is highly variable and depends on age, weight, and severity of deficiency. Typical doses range from 25-50 mg/kg/dose IV or IM, not to exceed 2 grams per dose. Refer to specific pediatric guidelines or protocols. * **Eclampsia/Preeclampsia:** Generally not recommended in children unless in specific, severe cases and under expert guidance. Dosing is not well-established. * **Torsades de Pointes:** 25-50 mg/kg IV, not to exceed 2 grams. May be followed by infusion. ## Dose Adjustments * **Renal Impairment:** Magnesium is renally excreted. Use with caution in patients with renal impairment. Reduce dose and monitor serum magnesium levels closely. In severe renal impairment, magnesium administration may be contraindicated. ## Contraindications * Hypermagnesemia * Heart block greater than first degree (unless a temporary pacemaker is in place) * Myocardial infarction (in certain situations, e.g., cardiogenic shock) * Severe renal impairment (relative contraindication for IV use) ## Adverse Effects * **Common:** Flushing, sweating, hypotension, nausea, vomiting, thirst, drowsiness, decreased reflexes, muscle weakness. * **Serious:** Respiratory depression, cardiac arrhythmias, cardiac arrest, hypermagnesemia (leading to lethargy, confusion, hyporeflexia, hypotension, bradycardia, respiratory paralysis, and cardiac arrest). ## Key Drug Interactions * **Neuromuscular Blockers:** Magnesium can potentiate the neuromuscular blocking effects of agents like succinylcholine and nondepolarizing muscle relaxants. * **Calcium Salts:** Can antagonize the cardiac and CNS effects of magnesium. * **Nifedipine:** Concurrent use may lead to profound hypotension. * **Antibiotics (Tetracyclines, Quinolones):** Magnesium can decrease the absorption of orally administered tetracyclines and fluoroquinolones; separate administration by at least 2 hours. ## Monitoring * **Serum Magnesium Levels:** Essential to monitor, especially with prolonged therapy or in patients with renal impairment. Therapeutic range is typically 1.7-2.2 mmol/L (4-5.5 mg/dL). * **Renal Function:** Assess baseline and monitor as needed. * **Vital Signs:** Blood pressure, heart rate, respiratory rate. * **Deep Tendon Reflexes:** Monitor for loss of reflexes, an early sign of hypermagnesemia. * **Urine Output:** Adequate urine output is necessary for magnesium excretion. * **ECG:** In patients receiving high doses or for prolonged periods, or in those with cardiac conditions. ## Clinical Pearls * IV administration of magnesium can be associated with pain and phlebitis at the injection site; slow infusion rates and consider using a larger vein. * IM administration can be painful; consider administering into each buttock alternately and using lidocaine as a diluent per local protocol. * Hypermagnesemia is the primary toxicity concern. Always consider renal function and monitor for signs and symptoms of toxicity. * Magnesium sulfate is a tocolytic agent in preterm labor but is not typically initiated for this indication outside of specific hospital protocols. * For acute hypomagnesemia, oral magnesium supplementation may be an alternative, but IV or IM administration is required for immediate correction. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the official prescribing information and relevant guidelines for complete and up-to-date details before making any clinical decisions. Local protocols and patient-specific factors may necessitate variations in dosing and management.